+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID02622581

National Clinical Research Platform Assessing Molecular Testing, Treatment, and Outcomes in Non-Small and Small Cell Lung Cancer Patients

Led by AIO-Studien-gGmbH · Updated on 2026-10-09

14500

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a large, open, non-interventional clinical research platform to study patients with non-small cell lung cancer NSCLC and small cell lung cancer SCLC in Germany. The study aims to assess molecular biomarker testing, treatments, and patient outcomes to better understand real-life care for these lung cancer types. A key focus is on molecular biomarker testing before starting first-line treatment in patients with advanced or metastatic NSCLC, helping to evaluate and improve care quality. This observational study collects detailed data on patient characteristics, biomarker testing including retesting, treatment decisions, various systemic anticancer therapies, radiotherapies, surgeries, supportive therapies, and disease progression. Data are gathered at baseline and updated at least every three months. The study includes several patient groups based on cancer stage and type, including those receiving systemic therapy, surgery, radiotherapy, or best supportive care. A decentralized tissue repository is also being established for future scientific biomarker research. Participants will provide written informed consent and complete patient-reported outcomes assessing quality of life, physical and psychological well-being, and anxietydepression. Data collection continues over three years with updates on treatment response, progression-free and overall survival, and other health-related measures. This comprehensive approach aims to improve understanding of lung cancer treatment and patient experience in routine practice.

CONDITIONS

Brief Title

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

Research Team

A

Annika Groth

P

Paula Ludwig

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here